What lab test is used to check for gluten sensitivity or celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for Celiac Disease

The IgA tissue transglutaminase antibody (tTG-IgA) is the preferred first-line screening test for celiac disease, with sensitivity of 90-96% and specificity >95%. 1, 2

Primary Screening Test

  • IgA tissue transglutaminase antibody (tTG-IgA) should be ordered as the initial test in patients over 2 years of age, as it supplants older gliadin antibody testing. 1
  • Total IgA level must be measured simultaneously to rule out IgA deficiency, which occurs in 1-3% of celiac disease patients and would cause false-negative results. 2, 3
  • Testing must be performed while the patient is consuming a gluten-containing diet (at least 10g daily for 6-8 weeks) to avoid false-negative results. 2, 3

Confirmatory Serologic Testing

  • When tTG-IgA levels are >10× the upper limit of normal, IgA endomysial antibody (EMA-IgA) should be performed as a confirmatory test with excellent specificity of 99.6%. 2, 3
  • The combination of markedly elevated tTG-IgA (>10× upper limit) plus positive EMA-IgA approaches 100% positive predictive value for celiac disease. 2

Testing in IgA-Deficient Patients

  • If IgA deficiency is detected, switch to IgG-based tests: IgG deamidated gliadin peptide (DGP-IgG) or IgG tissue transglutaminase (tTG-IgG). 2, 3
  • IgG-based tests are markedly less accurate in patients with normal IgA levels and should not be used in that setting. 1, 2

Special Pediatric Considerations

  • In children under 2 years of age, tTG-IgA testing should be combined with IgG and IgA deamidated gliadin peptides to improve sensitivity. 1, 3

Genetic Testing

  • HLA-DQ2 and HLA-DQ8 testing has >99% negative predictive value—absence of both alleles essentially rules out celiac disease. 2, 3
  • HLA testing is useful when celiac disease is strongly suspected despite negative serology, in patients with equivocal biopsy findings, or in patients already on a gluten-free diet who were never properly tested. 2

Gold Standard Confirmation

  • Upper endoscopy with small bowel biopsy remains the gold standard for diagnosis in adults, with multiple specimens (ideally 6 biopsies: 1-2 from duodenal bulb and at least 4 from second part of duodenum or beyond) required. 2, 3
  • Characteristic histologic findings include villous atrophy, crypt lengthening, and increased intraepithelial lymphocytes. 1, 2

Tests That Should NOT Be Used

  • IgA and IgG antigliadin antibodies are no longer recommended for primary detection, as they have inferior diagnostic performance compared to tTG-IgA and EMA. 1
  • Combining multiple serologic tests instead of tTG-IgA alone may marginally increase sensitivity but reduces specificity and is not recommended in low-risk populations. 1

Critical Pitfall to Avoid

  • Never initiate a gluten-free diet before completing diagnostic testing, as this leads to false-negative serology and inconclusive biopsies. 2, 3
  • Patients who have already started a gluten-free diet must resume normal diet with three slices of wheat bread daily for 1-3 months before repeat testing. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Celiac Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.